TrialDiabetes, obesity & metabolism2018

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET).

Julio Rosenstock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.